Host: |
Rabbit |
Applications: |
WB/IF |
Reactivity: |
Human/Mouse/Rat |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Rabbit polyclonal antibody anti-HNRantibody (1-285) is suitable for use in Western Blot and Immunofluorescence research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
PBS with 0.01% Thimerosal, 50% Glycerol, pH7.3. |
Purification: |
Affinity purification |
Dilution Range: |
WB 1:500-1:2000IF/ICC 1:50-1:100 |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
HNRNPAB |
Gene ID: |
3182 |
Uniprot ID: |
ROAA_HUMAN |
Immunogen Region: |
1-285 |
Immunogen: |
Recombinant fusion protein containing a sequence corresponding to amino acids 1-285 of human HNRPAB (NP_004490.2). |
Immunogen Sequence: |
MSEAGEEQPMETTGATENGH EAVPEGESPAGAGTGAAAGA GGATAAPPSGNQNGAEGDQI NASKNEEDAGKMFVGGLSWD TSKKDLKDYFTKFGEVVDCT IKMDPNTGRSRGFGFILFKD AASVEKVLDQKEHRLDGRVI DPKKAMAMKKDPVKKIFVGG LNPEATEEKIREYFGEFGEI EAIELPMDPKLNKRRGFVFI TFKEEEPVKKVLEKKFHTVS GSKCEIKVAQPKEVYQQQQ |
Tissue Specificity | Ubiquitous. |
Post Translational Modifications | Dimethylation at Arg-322 is probably asymmetric. |
Function | Binds single-stranded RNA. Has a high affinity for G-rich and U-rich regions of hnRNA. Also binds to APOB mRNA transcripts around the RNA editing site. |
Protein Name | Heterogeneous Nuclear Ribonucleoprotein A/BHnrnp A/BApobec1-Binding Protein 1Abbp-1 |
Cellular Localisation | NucleusCytoplasmLocalized In Cytoplasmic Mrnp Granules Containing Untranslated Mrnas |
Alternative Antibody Names | Anti-Heterogeneous Nuclear Ribonucleoprotein A/B antibodyAnti-Hnrnp A/B antibodyAnti-Apobec1-Binding Protein 1 antibodyAnti-Abbp-1 antibodyAnti-HNRNPAB antibodyAnti-ABBP1 antibodyAnti-HNRPAB antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance